UHPLC-HRMS Method for Repurposing FDA Approved Drugs: Primaquine and its Metabolites as Anticancer Therapeutics

机译：用于修复FDA批准的药物的UHPLC-HRMS方法：原序及其代谢产物作为抗癌治疗方法

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

1. A rapid and sensitive UHPLC-HRMS method was used to identify metabolites of Primaquine present in MCF-7 cells. 2. 6-desmethylprimaquine was detected in MCF-7 extracts.

机译：1.使用快速敏感的UHPLC-HRMS方法来鉴定MCF-7细胞中存在的原序列的代谢物。在MCF-7提取物中检测到6-DESMethylprimaquine。

著录项

来源
《American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics》|2012年||共1页
会议地点
作者
Samantha M. Mahmoud; Dil Ramanathan;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类 TB994.5-53;
关键词

相似文献

外文文献
中文文献
专利

1. Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection [J] . Ashwini Benedict, Neha Bansal, Svetlana Senina, Frontiers in Microbiology . 2015,第6期

机译：重新使用FDA批准的药物作为治疗裂谷热病毒感染的疗法
2. Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations [J] . Soodeh Mahdian, Mahboobeh Zarrabi, Yunes Panahi, Informatics in Medicine Unlocked . 2021,第a期

机译：通过在硅中释放FDA批准的药物来对抗Covid-19，在Silico 方法：通过虚拟筛选和分子动态模拟靶向SARS-COV-2 RDRP酶和宿主细胞受体（ACE2，CD147）
3. In silico drug repurposing of FDA-approved drugs to predict new inhibitors for drug resistant T3151 mutant and wild-type BCR-ABL1: A virtual screening and molecular dynamics study [J] . Sohraby Farzin, Bagheri Milad, Aliyar Masoud, Journal of molecular graphics & modelling . 2017,第期

机译：在Silico批准的药物重新批准FDA批准的药物中，以预测耐药性T3151突变体和野生型BCR-ABL1的新抑制剂：虚拟筛选和分子动力学研究
4. UHPLC-HRMS Method for Repurposing FDA Approved Drugs: Primaquine and its Metabolites as Anticancer Therapeutics [C] . Samantha M. Mahmoud, Dil Ramanathan American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：用于修复FDA批准的药物的UHPLC-HRMS方法：原序及其代谢产物作为抗癌治疗方法
5. Molecular Determinants for Binding of the FDA-Approved Drugs in Proteins – A Data Mining and Advanced Quantum Chemical Study [D] . Alqahtani, Saad. 2017

机译：FDA批准的药物与蛋白质结合的分子决定因素–数据挖掘和先进的量子化学研究
6. Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection [O] . Ashwini Benedict, Neha Bansal, Svetlana Senina, 2020

机译：重新使用FDA批准的药物作为治疗裂谷热病毒感染的疗法
7. >Repurposing of FDA Approved Drugs as COVID-19 Therapeutics: Safety Concerns and Contraindications of Drugs in Clinical Trials [O] . Ravinder Naik Dharavath, Meenu Dutt, Sunil Kumar, 2020

机译： >重新批准FDA批准的药物作为Covid-19治疗方法：临床试验中药物的安全问题和禁忌症
8. Guidance for FDA Staff and Industry: Marketed Unapproved Drugs. Compliance Policy Guide. Sec. 440.100 Marketed New Drugs Without Approved NDAs or ANDAs (September 19, 2011) [R] . 2011

机译：FDa工作人员和行业指南：未经批准的未经批准的药物。合规政策指南。秒。 440.100未经批准的NDa或aNDa上市的新药（2011年9月19日）

UHPLC-HRMS Method for Repurposing FDA Approved Drugs: Primaquine and its Metabolites as Anticancer Therapeutics

摘要

著录项

相似文献

相关主题

期刊订阅